CRASH2 and TXA in Trauma

    NextPrevious

    CRASH2 and TXA in Trauma

    The use of Transexamic (spell that 10 times fast) Acid, or TXA, in trauma is largely based on the CRASH2 trial. This was a large, multi-center, randomized controlled trial with over 20,000 patients that demonstrated a mortality benefit of TXA for trauma patients when initiated within 3 hours of the injury. The NNT is 68, with an absolute risk reduction of 1.5%. None of the secondary outcomes of the study showed any benefit (including need for transfusion, amount of products transfused, need for surgical intervention, or thromboembolic events).  There was added benefit for patients in significant shock with systolic blood pressures less than 75mmHg.

    In short, TXA works by inhibiting fibrinolysis. It has other uses outside the trauma room, which we won’t discuss here.

    The trial used a loading dose of 1gram over 10 minutes, followed by a second dose of 1g infused over the next 8 hours. I have often ordered the first gram, but have had patients who were in our department for some more time (rather than immediately making it to the SICU or OR) for whom I have not ordered the second dose. As we all know, the momentum of ED orders and procedures carrying forward (see those vent settings for an example, or your copy/pasted initial HPI in every note up to the discharge summary) is influential in the patient’s care. Consider placing the order for the second dose. Food for thought.

    • Welcome! This is the website for the Mount Sinai Emergency Ultrasound Division. It serves as an information resource for residents, fellows, medical students and others seeking information about point-of-care ultrasound. There is a lot ofRead more

    • Bag Mask Ventilation During Intubation

      A few days ago NEJM published the results of an investigation with profound implications for our specialty.  A group of intensivists and anesthesiologists conducted a multicenter, randomized trial conducted in seven ICUs to study theRead more

    • Gastric Emptying for Acute Poisonings

      At the request of department leadership, we will be revisiting methods of gastric decontamination for today’s pearl.  Two methods in particular. Ipecac-induced emesis and gastric lavage are two procedures that we read about in medicalRead more

    • Pacemakers Review pt. 3

      Today we will review complications associated w/ implanted pacemakers that you may encounter in the ED and thus ought to be familiar with. Generally, complications can be divided into two categories: early vs. late EarlyRead more

    • Pacemakers Review Pt. 2

      Cardiac pacing as an intervention can be conceptualized as addressing problems in electrophysiological conduction and/or.  So, for example, if there is a disruption in the electrical continuity between the atrium and the ventricle, a pacerRead more

    • Pacemakers Review Pt. 1

      The pursuit of mastery over cardiovascular emergencies demands a rough familiarity with implanted devices which includes why they get implanted in the first place (indications), how they work, how they malfunction, and how they affectRead more

    • In honor of a rosh review question that I got wrong, lets review Lyme disease!   Lyme disease is caused by the spirochete Boriella burgdorferi, transmitted to humans through tick bites from ixodes ticks. Location:Read more

    • NGT INSERTION

      Your patient has an SBO and has repeated bilious emesis on the side. The surgery team is in the OR and they ask if you can place the nasogastric tube (NGT). Lets review proper NGTRead more

    • No, that’s not an olive. That’s Pyloric Stenosis!

      Inspired by what appears to have been a very interesting day in the Peds ED, lets review a rare but interesting pediatric entity: PYLORIC STENOSIS Background: MC in Males (5:1) & firstborn children (30%) UsuallyRead more

    NextPrevious